Alivus Life Sciences Limited (NSE:ALIVUS)

Alivus Life Sciences Revenue

Alivus Life Sciences had revenue of 6.82B INR in the quarter ending September 30, 2026, with 15.99% growth. This brings the company's total for the last twelve months to 26.84B, up 8.19% year-over-year. In the fiscal year ending March 31, 2026, Alivus Life Sciences had annual revenue of 25.52B with 6.91% growth. That makes Alivus Life Sciences the 14,885th largest company in the world by revenue and 771st in India.

• Revenue (ttm): 26.84B
• Revenue Growth: +8.19%
• P/S Ratio: 6.61
• Revenue / Employee: 11.82M
• Employees: 2,272
• Market Cap: 177.53B

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• outside India 13.88B 54.4%
• India 11.64B 45.6%

Fiscal year ended Mar 31, 2026 See the full Alivus Life Sciences breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	25.52B	1.65B	6.91%
Mar 31, 2025	23.87B	1.04B	4.54%
Mar 31, 2024	22.83B	1.22B	5.64%
Mar 31, 2023	21.61B	380.06M	1.79%
Mar 31, 2022	21.23B	2.38B	12.63%

Data Source: S&P Global Market Intelligence Last updated: Oct 29, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 9, 2026

Data Sources Report a data error